318 related articles for article (PubMed ID: 23748101)
21. Minocycline inhibits LPS-induced retinal microglia activation.
Wang AL; Yu AC; Lau LT; Lee C; Wu le M; Zhu X; Tso MO
Neurochem Int; 2005 Jul; 47(1-2):152-8. PubMed ID: 15904993
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of macular function using focal macular electroretinography in eyes with macular edema associated with branch retinal vein occlusion.
Ogino K; Tsujikawa A; Murakami T; Muraoka Y; Akagi-Kurashige Y; Ishihara K; Miyamoto K; Nakamura H; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8047-55. PubMed ID: 21911591
[TBL] [Abstract][Full Text] [Related]
23. Quantitative Optical Coherence Tomography Angiography Features and Visual Function in Eyes With Branch Retinal Vein Occlusion.
Samara WA; Shahlaee A; Sridhar J; Khan MA; Ho AC; Hsu J
Am J Ophthalmol; 2016 Jun; 166():76-83. PubMed ID: 27038893
[TBL] [Abstract][Full Text] [Related]
24. Microglia Activation and Recruitment of Circulating Macrophages During Ischemic Experimental Branch Retinal Vein Occlusion.
Ebneter A; Kokona D; Schneider N; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):944-953. PubMed ID: 28170538
[TBL] [Abstract][Full Text] [Related]
25. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
26. Analysis of retinal nonperfusion using depth-integrated optical coherence tomography images in eyes with branch retinal vein occlusion.
Sakimoto S; Gomi F; Sakaguchi H; Akiba M; Kamei M; Nishida K
Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):640-6. PubMed ID: 25574041
[TBL] [Abstract][Full Text] [Related]
27. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
28. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
[TBL] [Abstract][Full Text] [Related]
29. Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat.
Rehak M; Hollborn M; Iandiev I; Pannicke T; Karl A; Wurm A; Kohen L; Reichenbach A; Wiedemann P; Bringmann A
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2359-67. PubMed ID: 18806298
[TBL] [Abstract][Full Text] [Related]
30. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
31. Effect of glial cell line-derived neurotrophic factor on retinal function after experimental branch retinal vein occlusion.
Ejstrup R; Cour Ml; Kyhn MV; Heegaard S; Kiilgaard JF
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6207-13. PubMed ID: 22915030
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
Simsek M; Citirik M; Ozates S; Ozkoyuncu D
Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective Effects of FGF2 and Minocycline in Two Animal Models of Inherited Retinal Degeneration.
Di Pierdomenico J; Scholz R; Valiente-Soriano FJ; Sánchez-Migallón MC; Vidal-Sanz M; Langmann T; Agudo-Barriuso M; García-Ayuso D; Villegas-Pérez MP
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4392-4403. PubMed ID: 30193320
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective Effect of Lutein on NMDA-Induced Retinal Ganglion Cell Injury in Rat Retina.
Zhang C; Wang Z; Zhao J; Li Q; Huang C; Zhu L; Lu D
Cell Mol Neurobiol; 2016 May; 36(4):531-40. PubMed ID: 26119305
[TBL] [Abstract][Full Text] [Related]
36. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
[TBL] [Abstract][Full Text] [Related]
38. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
Kim JH; Shin JP; Kim IT; Park DH
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
[TBL] [Abstract][Full Text] [Related]
39. Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration.
Scholz R; Sobotka M; Caramoy A; Stempfl T; Moehle C; Langmann T
J Neuroinflammation; 2015 Nov; 12():209. PubMed ID: 26576678
[TBL] [Abstract][Full Text] [Related]
40. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
